Please ensure Javascript is enabled for purposes of website accessibility

Why NovoCure, Lumber Liquidators, and SodaStream International Jumped Today

By Dan Caplinger - Apr 3, 2017 at 4:34PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These stocks gained ground despite pressure in the market. Find out why.

The stock market posted lackluster performance on Monday, as investors focused on economic and industry data in advance of the beginning of first-quarter earnings season. In particular, some weaker-than-expected performance from the auto industry put pressure on the overall market, and major market benchmarks closed the day with modest losses that marked a significant recovery from their worst levels of the day. Helping to ease the negativity in the market was good news from several individual companies, and NovoCure (NVCR -1.20%), Lumber Liquidators (LL 2.61%), and SodaStream International (SODA) were among the best performers on the day. Below, we'll look more closely at these stocks to tell you why they did so well.

NovoCure climbs on encouraging data

Shares of NovoCure soared almost 40% in the wake of good news concerning the latest information on the company's ongoing clinical trials. On Friday, NovoCure said that its proprietary Tumor Treating Fields therapy had shown solid results in several different applications, including in combination with paclitaxel for recurrent ovarian cancer, as well as with gemcitabine and nab-paclitaxel for advanced pancreatic cancer. Another phase 2 trial will combine TTFields with other medications in fighting malignant mesothelioma. Then yesterday, NovoCure said that its phase 3 EF-14 trial adding its Optune TTFields system to standard chemotherapy improved survival rates for newly diagnosed glioblastoma patients. The combination of results encouraged investors that NovoCure has a lot of potential going forward, and shareholders are reaping the rewards.

Room with Lumber Liquidators flooring.

Image source: Lumber Liquidators.

Lumber Liquidators keeps building

Lumber Liquidators stock climbed 7%, adding to substantial gains from last week. For the past couple of years, the wood-flooring specialist has suffered from multiple controversies, but investors appear increasingly confident that the retailer has turned the corner and can start to enjoy the benefits of an ongoing strong housing market and appetite for home-improvement projects. In particular, Lumber Liquidators has shown renewed growth characteristics over the past couple of quarters, bouncing back from huge declines in same-store sales and regaining its footing. The stock has clawed back about half of its losses since early 2015, but it could have further room to run if its financial results continue to improve markedly.

SodaStream International says April Fool!

Finally, shares of SodaStream gained 6%. The home-carbonation system seller did an April Fool's Day prank over the weekend, engaging Hollywood celebrity Paris Hilton to roll out the fake launch of a new type of beverage called NanoDrop. In revealing the joke, SodaStream emphasized that the problems involved in plastic water bottle pollution are real, and although Hilton's solution was a prank, the beverage system-maker's carbonators can achieve real-world gains in fighting the same problems. Whether the joke will pay off in sales remains to be seen, but it appears that the campaign got at least some attention from investors and shoppers alike.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

SodaStream International Ltd. Stock Quote
SodaStream International Ltd.
Lumber Liquidators Holdings, Inc. Stock Quote
Lumber Liquidators Holdings, Inc.
$10.61 (2.61%) $0.27
NovoCure Stock Quote
$74.69 (-1.20%) $0.91

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.